PetMed Express Faces Delisting Notice

TL;DR

PETS got an 8-K for delisting notice - big trouble brewing.

AI Summary

PetMed Express, Inc. filed an 8-K on August 20, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, incorporated in Florida with its principal executive offices in Delray Beach, is subject to this filing as of August 20, 2025.

Why It Matters

This filing indicates potential issues with PetMed Express's compliance with stock exchange listing standards, which could impact its stock trading and investor confidence.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's continued trading on an exchange.

Key Numbers

• 001-42429 — SEC File Number (Identifies the company's filing history with the SEC.)
• 65-0680967 — I.R.S. Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• PetMed Express, Inc. (company) — Registrant
• August 20, 2025 (date) — Date of earliest event reported
• Florida (location) — State of incorporation
• Delray Beach (location) — Address of principal executive offices
• 420 South Congress Avenue (address) — Principal executive offices street address

FAQ

Filing Documents

• pets-20250820.htm (8-K) — 31KB
• 0001040130-25-000051.txt ( ) — 186KB
• pets-20250820.xsd (EX-101.SCH) — 2KB
• pets-20250820_def.xml (EX-101.DEF) — 16KB
• pets-20250820_lab.xml (EX-101.LAB) — 27KB
• pets-20250820_pre.xml (EX-101.PRE) — 16KB
• pets-20250820_htm.xml (XML) — 4KB

01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On August 20, 2025, PetMed Express, Inc. (the " Company ") received a notice (the " Notice ") from the Nasdaq Stock Market LLC (" Nasdaq "), which indicated that, as a result of the Company's delay in filing its Annual Report on Form 10-K for its fiscal year ended March 31, 2025 (the " Annual Report ") and its Quarterly Report on Form 10-Q for the period ended June 30, 2025 (the " Quarterly Report "), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the " Listing Rule "), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the U.S. Securities and Exchange Commission (the " SEC "). The Notice states that the Company has until September 1, 2025, which is 60 days from the date of the Nasdaq letter received on July 2, 2025, in connection with the delinquency of the Company's filing of its form 10-K for the period ended March 31, 2025 (the "Initial Delinquent Filing "), to submit to Nasdaq a plan to regain compliance with the Listing Rule. If Nasdaq accepts the Company's plan, it may grant the Company an exception of up to 180 calendar days from the due date of the Initial Delinquent Filing, or until December 29, 2025, to regain compliance. The Notice has no immediate effect on the listing of the Company's common stock on Nasdaq. While the Company can provide no assurances as to timing, the Company continues to work diligently to complete its Annual Report and Quarterly Report and intends to file them as promptly as possible to regain compliance with the Listing Rule. Cautionary Note Regarding Forward-Looking Statements This Current Report on Form 8-K contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements contained in this Current Report on Form 8

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 25, 2025 PETMED EXPRESS, INC. By: /s/ Douglas Krulik Name: Douglas Krulik Title: Principal Financial Officer and Treasurer 3

View Full Filing

View this 8-K filing on SEC EDGAR